Gene · 8295
Papers1,639
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,639
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Exome variant prioritization in a large cohort of hearing-impaired individuals indicates IKZF2 to be associated with non-syndromic hearing loss and guides future research of unsolved cases. | Hum Genet | 2024 | 39406892 | PubTator, text mining | PubMed |
| Nuclear receptor corepressor 1 levels differentially impact the intracellular dynamics of mutant thyroid hormone receptors associated with resistance to thyroid hormone syndrome. | Mol Cell Endocrinol | 2024 | 39299378 | PubTator, text mining | PubMed |
| Structure of the human TIP60-C histone exchange and acetyltransferase complex. | Nature | 2024 | 39260417 | PubTator, text mining | PubMed |
| Inhibition of Thyroid Hormone Signaling in the Zona Incerta Alters Basal Metabolic Rate, Behavior, and Serum Glucocorticoids in Male Mice. | Thyroid | 2024 | 39189416 | PubTator, text mining | PubMed |
| Structure of the human TIP60 complex. | Nat Commun | 2024 | 39154037 | PubTator, text mining | PubMed |
| Structural insights into the human NuA4/TIP60 acetyltransferase and chromatin remodeling complex. | Science | 2024 | 39088653 | PubTator, text mining | PubMed |
| Deciphering the etiology of undiagnosed ocular anomalies along with systemic alterations in pediatric patients through whole exome sequencing. | Sci Rep | 2024 | 38909058 | PubTator, text mining | PubMed |
| Identification of key genes and immune infiltration in peripheral blood biomarker analysis of delayed cerebral ischemia: Valproic acid as a potential therapeutic drug. | Int Immunopharmacol | 2024 | 38897129 | PubTator, text mining | PubMed |
| Comparative Phenotyping of Mice Reveals Canonical and Noncanonical Physiological Functions of TRα and TRβ. | Endocrinology | 2024 | 38889231 | PubTator, text mining | PubMed |
| Impact of the thyroid hormone T3 and its nuclear receptor TRα1 on colon cancer stem cell phenotypes and response to chemotherapies. | Cell Death Dis | 2024 | 38693105 | PubTator, text mining | PubMed |
| A Rare Mutation in TRRAP Gene and the Expanded New Phenotype. | Indian J Pediatr | 2024 | 38565765 | PubTator, text mining | PubMed |
| A druggable conformational switch in the c-MYC transactivation domain. | Nat Commun | 2024 | 38424045 | PubTator, text mining | PubMed |
| The DNA damage sensor ATM kinase interacts with the p53 mRNA and guides the DNA damage response pathway. | Mol Cancer | 2024 | 38263180 | PubTator, text mining | PubMed |
| Unraveling the Behavior of Intrinsically Disordered Protein c-Myc: A Study Utilizing Gaussian-Accelerated Molecular Dynamics. | ACS Omega | 2024 | 38250404 | PubTator, text mining | PubMed |
| The allosteric mechanism of mTOR activation can inform bitopic inhibitor optimization. | Chem Sci | 2024 | 38239681 | PubTator, text mining | PubMed |
| miRNAs as predictive biomarkers of response to treatment in pediatric patients with acute lymphoblastic leukemia. | Oncol Lett | 2024 | 38192661 | PubTator, text mining | PubMed |
| Integrated multi-omics analyses identify anti-viral host factors and pathways controlling SARS-CoV-2 infection. | Nat Commun | 2024 | 38168026 | PubTator, text mining | PubMed |
| Computational analysis of protein-protein interactions of cancer drivers in renal cell carcinoma. | FEBS Open Bio | 2024 | 37964489 | PubTator, text mining | PubMed |
| Current and Emerging Therapeutic Targets for the Treatment of Cholangiocarcinoma: An Updated Review. | Int J Mol Sci | 2023 | 38203714 | PubTator, text mining | PubMed |
| The multi-faceted roles of R2TP complex span across regulation of gene expression, translation, and protein functional assembly. | Biophys Rev | 2023 | 38192347 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8295/papers?page=3